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Cancer of the thyroid is relatively uncommon, accounting for less
than 2% of all cancers in Canada and worldwide (Coleman et al,
1993; Ron, 1995; National Cancer Institute of Canada, 2000). It
consists of several morphologic types with distinct clinical and
epidemiological features. Whereas papillary and follicular carci-
nomas occur mainly in the younger age groups, anaplastic tumours
of thyroid are rare before 50 years of age. The female-to-male ratio
is approximately 3:1 for papillary and follicular carcinomas, while
medullary carcinoma occurs with almost equal frequency among
males and females (Pettersson et al, 1991; Akslen et al, 1993; Ron,
1995; Zheng et al, 1996). Recent studies have shown that thyroid
cancer incidence rates are steadily increasing in several countries
including the United States (Spitz et al, 1988; Zheng et al, 1996),
Sweden (Pettersson et al, 1991), Norway (Akslen et al, 1993) and
Britain (Dos Santos Silva and Swerdlow, 1993). These increases
have been accompanied by a change in the distribution of histo-
logic types, however. Radiation is known to be an important risk
factor (Ron et al, 1987; Spitz et al, 1988; Dos Santos Silva and
Swerdlow, 1993; Inskip et al, 1995; Zheng et al, 1996; Mao et al,
in press) but female hormonal and reproductive factors may also
be relevant (Preston-Martin et al, 1987; Levi et al, 1993; Galanti
et al, 1995; Paoff et al, 1995; Mack et al, 1999). 
Zheng et al (1996) analysed cancer registration data for the last
60 years and identified a strong birth cohort effect underlying the
observed increase in thyroid cancer incidence in both sexes in
Connecticut, USA. This study also suggested that the introduction
of radiation treatment for benign childhood conditions of the head
and neck between the 1920s and the 1950s was largely responsible
for the increasing temporal trends in thyroid cancer. We have
therefore examined time trends for thyroid cancer incidence in
Canada by age at diagnosis, time period and birth cohort between
1970 and 1996. 
MATERIALS AND METHODS 
Thyroid cancer incidence data for 1992 to 1995 were obtained
from the Canadian Cancer Registry (CCR) which replaced the
National Cancer Incidence Reporting System (NCIRS) of
Statistics Canada in 1992. Data for the province of Quebec were
excluded because improved reporting procedures were not imple-
mented there until 1981. The information regarding the CCR and
the quality of Canadian cancer incidence data has been well docu-
mented (Band et al, 1993; Gaudette and Lee, 1997). In general, the
cancer registry data included in this study are comparable and reli-
able, and 90% of thyroid cancers were pathologically confirmed
in the period 1969–1973, and 95% in the period 1984–1988 (Band
et al, 1993). 
Information on histological classification of thyroid cancer was
not consistently recorded by all provinces and territories in Canada
until 1983, although Ontario, Saskatchewan and British Colombia
collected such data even in earlier decades. The three provincial
cancer registries used the Systematized Nomenclature of Pathology
for histological classification until 1978, and all the records have
been subsequently converted to the International Classification of
Disease for Oncology (ICD-O). Based on the ICD-O first and
second editions, thyroid cancer is coded as topography site codes
193 and C73, respectively. In this study, cases were subdivided into
3 broad histological groups: papillary, follicular and other specified
or not otherwise specified (NOS) carcinomas. 
We first contrasted average 3-year age-adjusted rates for the
period 1970–72 with that for 1994–96 for both sexes. We then
compared the rates in 4 broad age groups, i.e., 10–24, 25–44,
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cancer were evaluated through Poisson regression models using
annual rates for all ages as well as for the described broad age
groups. Correspondingly, the average annual percent changes
(AAPC) during the study period were derived from the regression
coefficients of those models. All age-adjusted incidence rates were
calculated using direct standardization with the World Standard
Population as the standard (Parkin et al, 1992). 
In analyses integrating age at diagnosis, time period of diag-
nosis and birth cohort, age was grouped into 5-year intervals
(15–19 years to 80–84 years). The period of diagnosis covered five
equal 5-year intervals from 1972 to 1996. Corresponding to these
age groups and time periods, a total of 18 overlapping 10-year
birth cohorts (1887–1896 to 1972–1981, identified by the central
year of birth from 1892 to 1977) were available for modelling of
the incidence data. 
A Poisson regression model was used to estimate the age, period
and cohort effects. The model assumes that the number of cancer
cases follows a Poisson distribution and the incidence rates are a
multiplicative function of the included model parameters, making the
logarithm of the rates an additive function of the parameters (Clayton
and Schifflers, 1987a, 1987b; Holford, 1991, 1992). For example, the
form of the age-period-cohort (APC) model was given by 
log (dij/pij) = µ + α i + β j + γ k
where dij denotes the number of the incident cases in the ith age
group and jth period; pij, the population at risk in the ith age group
and jth period; α i the effect of the ith age group; β j, the effect of
the jth period category; and γ k, the effect of the kth cohort category
(k = I – i + j when i = 1,2,...,I). Inherent in the three-factor APC
model is the non-identifiability problem: parameters for age, period
and cohort are not uniquely estimable because of the exact linear
dependence of the regression variables (cohort = period – age)
(Holford, 1992; Tarone and Chu, 1996). Although several methods
for dealing with the non-identifiability problem have been proposed,
there is no consensus in the literature as to which method is
optimal. In our study, 3-factor APC models for the data were fitted
by constraining the regression coefficients for the two extreme
cohorts as zero, an approach commonly used in several previous
studies (Tarone and Chu, 1996; Shahpar and Li, 1999;
O’Callaghan et al, 2000). To compare the curvatures or the depar-
ture of the time trends in incidence between females and males in
a single model (using an additional variable to define the gender),
we introduced interaction terms between sex and the 3 time factors
into the above general model (Holford, 1992; Liu et al, 2000).
Changes in age, period and cohort effects were estimated along
with the interaction terms. 
Parameters of the models were estimated by means of the
maximum likelihood method with SAS procedure GENMOD
(release 6.12, SAS Institute Inc, Cary, NC 1997). The goodness-
of-fit of models was evaluated using the deviance, defined to be
twice the difference between the maximum achievable log likeli-
hood and the log likelihood at the maximum likelihood estimates
of the regression parameters. Specific effects (e.g., period effects)
were tested by comparing the difference in deviance between
models with and without a term for the effect. 
RESULTS 
A total of 18 804 incident cases of thyroid cancer were registered
in Canada excluding Quebec between 1970 and 1996. Of these,
13 975 (74.3%) were diagnosed in women and 4 829 (25.7%) in
men. According to data for provinces of Ontario, Saskatchewan
and British Columbia, 60% of 13 712 incident cases of thyroid
cancer were classified as papillary carcinomas, 15% as follicular
carcinoma and 25% as NOS. 
The overall age-adjusted rate among females and males
increased substantially, from 3.5 and 1.1 per 100 000 population in
1970–72 to 6.7 and 2.2 per 100 000 population in 1994–96,
respectively. The increasing trend among females appears to be
more marked than that among males especially since the early
1980s (Figure 1), mostly due to an increase in papillary carcinoma
which more than tripled between 1970–72 and 1994–96, from 1.4
to 5.4 per 100 000 among females and from 0.4 to 1.4 per 100 000
among males. Other types remained more or less stable (data
available upon request). 
The overall rate of increase in thyroid cancer among females
was only slightly higher than that among males (AAPC: 3.5% vs
3.2%). However, the age-specific patterns of change were different
across genders. For example, reproductive age-group women (age
25–44) experienced the most rapid increase (AAPC = 3.7%),
while elderly women (age 65–84) had only a slight increase
(AAPC = 0.7%) over the study period. In contrast, the differences
in AAPCs between age groups were relatively smaller among men
(Table 1). 
The age-specific incidence rates by birth cohort are plotted in
Figures 2 and 3 for females and males, respectively. The incidence
showed an appreciable increase since the birth cohort of 1922 for
both women and men, although the birth cohort effect was more
evident among women. A high rate plateau was observed among
those aged 30 to 64 years for women, while the incidence rates for
men increased by age group, to the highest among the elderly aged
65 to 79 years (Figures 2 and 3). 
Age-period-cohort models were fitted to the data for 1972
through 1996 for females and males separately. Table 2 summa-
rizes the results of the modelling. Modelling of the data for
females suggested that a full age-period-cohort model provided a
significant improvement over either the age-cohort model or age-
period model. The birth cohort effect was more pronounced than
the period effect in terms of the ratio of the deviance and degrees
of freedom. The full model was thus considered satisfactory for
the time trends in thyroid cancer incidence among females. On the
other hand, the age-cohort model fits the data for males well.
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Figure 1 Age-adjusted incidence rates of thyroid cancer by sex in Canada,
1970–72 to 1994–96, per 100 000 Neither the age-period model nor the full age-period-cohort model
achieved a better fit. Therefore, the best-fitting model of the data
for males showed a significant birth cohort effect in addition to an
age effect. 
All sex-curvature interactions with age, time period and birth
cohort were statistically significant (P < 0.05 or P < 0.01), indi-
cating that time trends among men differ significantly from
women in terms of age at diagnosis, time period and birth cohort
curvature effects. The contrast between the ‘unique’ trend lines
obtained from fitting an age-period-cohort model showed different
patterns between genders. For example, while the risk began to
decrease around the age 55 among women, it instead increased
sharply among men. On the other hand, the incidence trend rose
steadily since the birth cohort of 1932 among women, while no
clear changes were observed across the birth cohorts among men
(Figure 4). 
DISCUSSION 
Our results show that the overall age-adjusted incidence rates of
thyroid cancer have been increasing in Canada among both
females and males. The increase almost entirely comes from papil-
lary carcinoma of the thyroid, with the greatest increase among
young and middle-age women. This observation is similar to
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Table 1 Age-specific incidence rate of thyroid cancer (per 100 000 population) and
average annual percent change (AAPC) in Canada excluding Quebec, 1970–72 to
1994–96a
Age (year)
Female Male 
1970–72 1994–96 AAPCb 1970–72 1994–96 AAPCb
10–24 1.55 2.92 2.54** 0.37 0.74 1.67* 
25–44 4.43 11.04 3.65** 1.27 2.84 2.74** 
45–64 5.84 12.78 3.36** 1.97 4.56 2.93** 
65–84 8.16 10.69 0.66* 4.08 5.88 1.68** 
All agesa 3.26 6.82 3.50** 1.12 2.23 3.15** 
*P < 0.05; **P < 0.01 aRates were adjusted to the World Standard Population. bTrends
were estimated by Poisson regression. See the Methods. 
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Figure 2 Age-specific incidence rates of thyroid cancer by birth cohort
among women in Canada, per 100 000 
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Figure 3 Age-specific incidence rates of thyroid cancer by birth cohort
among men in Canada, per 100 000 
Table 2 Comparison and evaluation of age-period-cohort modelling of thyroid
cancer incidence by sex in Canada excluding Quebec, 1972–1996 
Terms in model Female Male 
d.fa Devianceb P valuec d.f Deviance P value 
Age 56 695.9 56 249.1
Age-period 52 113.7 0.0001 52 105.7 0.0001 
Age-cohort 39 68.2 0.0001 39 67.9 0.3279 
Age-period-cohort 36 26.7 36 64.5
ad.f: degree of freedom. bDeviance from the standard Poisson model. cP values
based on chi-square test refer to comparison between two-factor model with the full
age-period-cohort model. reports from the United States (Spitz et al, 1988; Zheng et al,
1996), Sweden (Pettersson et al, 1991), Norway (Akslen et al,
1993) and Britain (Dos Santos Silva and Swerdlow, 1993). Age-
period-cohort modelling further shows that both birth cohort and
period effects are responsible for the observed trends among
females, while a birth cohort effect is the main determinant for the
observed increase among males. More importantly, different sex
patterns in terms of age, period and birth cohort curvatures were
demonstrated, suggesting aetiologic heterogeneity between
women and men in the pathogenesis of the disease (Figure 4). 
Our results suggest that birth cohort effects are the major deter-
minants of the observed trends in this population. Previous
epidemiological studies have indicated that prior radiotherapy in
childhood increases the risk of thyroid cancer (Boice, 1986; Ron
et al, 1987; Spitz et al, 1988; Dos Santos Silva and Swerdlow,
1993; Inskip et al, 1995; Zheng et al, 1996; Mao et al, in press).
Shore (1992) estimated that the risk of thyroid cancer associated
with juvenile external irradiation is about 2.6 excess cancer/10 000
persons/year/gray. In Canada, ionizing radiation was used to treat
children with benign conditions of the head and neck (e.g.,
enlarged thymus, tonsillitis and adenoids) between the 1930s and
the 1960s. A population-based case–control study conducted in
Connecticut, USA estimated that 9% of the disease in the popula-
tion might be attributable to the prior radiotherapy to the head and
neck in infancy (Ron et al, 1987). 
Ionizing radiation is a main well-established risk factor for
thyroid cancer (Shore et al, 1985; Franceschi and Vecchia, 1994;
Ron, 1995). For the general population, diagnostic radiology may
be the main source of exposure to ionizing radiation, and an
increased risk associated with diagnostic X-rays is also biologi-
cally plausible (Shore et al, 1985; Franceschi and Vecchia, 1994).
Furthermore, the thyroid gland may be included in the radiation
field when either the upper body or the chest is exposed to X-rays.
The susceptibility to radiation-induced thyroid cancer is the
greatest for examinations occurring in childhood and adolescence
(Boice, 1986; Ron et al, 1987; Spitz et al, 1988). Thus, our results
suggest that the increasing trends in thyroid cancer incidence in
Canada could be associated with change in radiation exposure in
childhood and adolescence; nevertheless, the increases observed
are larger than can be explained by the levels associated with
current diagnostic procedures. A large prospective follow-up study
(Inskip et al, 1995) found no tendency for case subjects to have
experienced more X-ray procedures associated with a higher radi-
ation dose to the thyroid gland. Diagnostic radiation also cannot
satisfactorily explain the increases in the incidence observed only
among women aged 25–64 years and the continued increase
among recent birth cohorts. 
Because of the marked female to male excess of well-
differentiated thyroid cancers observed, a number of epidemiolog-
ical studies have examined possible associations between
hormones and other reproductive factors and the risk of thyroid
cancer (Preston-Martin et al, 1987; Levi et al, 1993; Galanti et al,
1995; Paoff et al, 1995; Mack et al, 1999). Unlike the pattern
observed for breast cancer, pregnancy and early menopause appear
to enhance the risk of thyroid cancer (Preston-Martin et al, 1987;
Levi et al, 1993). Furthermore, the association is more pronounced
for the papillary type than the follicular type (Levi et al, 1993;
Galanti et al, 1995). Among reproductive exposures, miscarriage
or abortion, particularly in the first pregnancy is the most consis-
tent risk factor (Preston-Martin et al, 1987; Levi et al, 1993; Ron,
1995). A recent pooled analysis (Negri et al, 1999) of original data
from 14 case–control studies of thyroid cancer showed that there is
a limited association with overall menstrual and reproductive
factors, while miscarriage of the first pregnancy posts a high risk
for developing papillary carcinoma (e.g., pooled OR 1.7 (95% CI
1.1–2.7)). In Canada, the therapeutic abortion rate for reproductive
age women increased from 9.7 per 1000 in 1974 to 14.7 per 1000
in 1994, with the highest rates among young women aged 18–29
years (Health Statistics Division, 1996). However, the controver-
sial findings regarding hormones and reproductive factors deserve
further research in which confounders are better controlled. 
More intensive diagnostic activity is another possible explana-
tion for the increasing trends, given increased use of more sophis-
ticated diagnostic methods (e.g., fine-needle biopsy, radio-isotope
thyroid scanning) together with broader indications for the
surgical removal of solitary nodules (Pettersson et al, 1991;
Akslen, 1993; Dos Santos Silva and Swerdlow, 1993; Ron, 1995).
Since papillary carcinomas have an indolent clinical course, inten-
sive diagnostic activity may be leading to the discovery of occult
papillary carcinomas. Corresponding to the rapid development in
advanced histopathological techniques since the late 1970s, an
increasing numbers of asymptomatic tumours of the thyroid may
have been detected. In addition, histopathological misclassifica-
tion cannot be ruled out in our data, as the introduction of new
WHO histological criteria in 1974 had some impact on the
changing temporal trends by histological subtype. It is likely,
therefore, that an early detection artefact identified as a period
effect in this study has played a role as well. Since that effect is
only statistically significant in women, one may readily speculate
that doctors may have increased their use of new diagnostic
methods particularly in young patients and females. Nevertheless,
the increase in papillary carcinoma and the underlying birth cohort
effects cannot be explained entirely by increasing diagnosis of
occult carcinomas or changes in classification. 
Other risk factors such as radioactive fallout (Akslen et al, 1993;
Dos Santos Silva and Swerdlow, 1993), iodine deficiency or
iodine excess, endemic goiter (Pettersson et al, 1991; Franceschi
and La Vecchia, 1994) and certain dietary factors appear to be
unlikely to explain the overall temporal trend and the birth cohort
pattern observed in this population. Since the causes of most
thyroid cancer have yet to be discovered, the effect of these risk
factors warrants further investigation. 
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Figure 4 Age, period and cohort effects on thyroid cancer incidence for
females (solid line) and males (dashed line) estimated by a three-factor
model with interaction terms for sex. The values for the first and last cohorts
are not displayed (Tarone and Chu, 1996) In conclusion, the steady increasing trends in the incidence of
thyroid cancer during recent decades appears to be real. No single
hypothesis regarding the associated risk factors can explain the
rapidly increasing incidence. The birth cohort pattern observed for
thyroid cancer incidence in the Canadian population suggests that
the hypothesis that radiation exposure in childhood and adoles-
cence is responsible for increasing risk of developing papillary
carcinoma should be further investigated. Changes in female
hormones and reproductive factors, particularly increased abor-
tions or miscarriages, may partially explain the rapidly increased
incidence among young and middle-aged women. Improved early
detection may also have played a role, and should be further inves-
tigated. Other unrecognized aetiologic factors remain to be identi-
fied. The differential age, period and cohort effects provide clues
to aetiologic heterogeneity in the pathogenesis of thyroid cancer
between females and males. 
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